Influence of the programmed cell death of lymphocytes on the immunity of patients with atopic bronchial asthma
© VODOUNON et al.; licensee BioMed Central Ltd. 2014
Received: 25 November 2013
Accepted: 28 February 2014
Published: 19 March 2014
Fairly recent data highlight the role of programmed cell death and autoimmunity, as potentially important factors in the pathogenesis of chronic obstructive airway diseases. The purpose of our research was to determine the influence of apoptotic factors on the immunity of patients with atopic bronchial asthma according to the degree of severity.
The study was performed on the peripheral blood of patients with atopic bronchial asthma with different severity. The Immunological aspects were determined with ELISA, the fluorimetric method and the method of precipitation with polyethylene glycol. And the quantification of the parameters of the programmed cell death was performed by the method of flow cytometry and electron microscopy method.
The data obtained from morphological and biochemical parameters show the deregulation of Programmed Death of lymphocytes of patients with atopic bronchial asthma but individual for each group of patients. This dysfunction might induce the secretion of autoantibodies against DNA. This could explain the accumulation of circulating immune complex with average size considered as the most pathogenic in patients with bronchial asthma especially in the patients of serious severity. It should be noted that Patients with bronchial asthma of mild and severe severity had different way and did not have the same degree of deficiency of the immune system.
These data suggested that apoptotic factor of lymphocytes may play an important role in controlling immunity of patients with atopic bronchial asthma.
KeywordsProgrammed cell death Immunity Atopic Bronchial Asthma
Each pathological process resembles a stereotypical reaction of the organism due to the action of various pathogens. Although there is a genetic and immunological specificity, all species highly organized (including humans) show practically the same stereotyped responses. Programmed cell death (PCD), which is similar to a natural physiological process [1–3] is a very illustrative example of the stereotypical reactions. An important progress in the study of the PCD concern the morpho-biochemical changes observed during apoptosis [4–6]. In this respect, with the current classification of programmed cell death we can note: PCD of type I- apoptosis, PCD of type II - autophagy and necrosis as PCD of type III . If before, the decisive role of PCD was attributed to induce this process (physiological: during apoptosis, supra-physiological during necrosis), now the differences from apoptosis and necrosis of the surrounding cells and the organism are in the foreground. On the other hand, the process of autophagy in normal cells is a possibility of renewal of organelles [8–10]. It was established that autophagy plays a vital role during embryogenesis and in the post-embryonic metamorphosis . The deregulation of this process plays an important role in many diseases such as: neurodegenerative diseases (Alzheimer’s and Parkinson’s) [7, 10, 12], myodystrophy and cardiomyopathy diseases [13, 14], the aging and infections  and malignant tumors . The intensification of the study on the process of cell death is due to the fact that there are several methods existing nowadays available to record the various manifestations of PCD and to analyze molecular mechanisms  which are tightly related to mechanisms of other important events (eg cell activation and associated biological signaling). The study of PCD proved to be productive and fruitful for the understanding of a certain number of important processes, including immune homeostasis and oncogenesis. In connection with the phenomenon of PCD, it was necessary to review a certain number of conceptual data of pathophysiology. In eukaryotes, PCD was previously considered as a negative process in view of the importance of identifying the phenomenon of necrosis. Nowadays, we have a better understanding of PCD: on the one hand, the death of cells in the body is seen as a natural process, and the existence of a multicellular organism requires a balanced relationship between life and death. Nevertheless, the role of apoptosis in the development of the pathological process is less obvious. It seems that this form of cell death (as opposed to necrosis) is not an indispensable component of the typical pathological process, but rather the malfunction of apoptosis is the cause of a certain number of diseases [6, 16, 17]. Thus, the relevance of this problem is defined by a correlation of the malfunction of PCD process with most diseases, including autoimmune diseases. The identification of the mechanisms of deregulation of the PCD associated with some specific diseases allows understanding the etiopathology of these diseases. The goal of our research was to determine the immunological characteristics and the biochemical and morphological parameters of PCD of lymphocytes of patients with atopic bronchial asthma (ABA) according to their degree of severity.
Materials and methods
Patients and blood sampling
The study was carried on the peripheral blood from relatively healthy individuals (n = 21) and asthmatic patients (n = 92). The group of patients was composed of individuals with different severity of asthma: 38 patients of mild severity with an average of 39 +/- 5 years, 20 patients of moderate severity (42+/- 5) and 34 patients of severe severity (42 +/- 5). At the time of blood collection, patients were hospitalized in the detachment of Pneumology and were not treated with glucocorticoid. All the donors were non smokers and were selected after consent. The collection of venous blood from donors was done in the morning before taking breakfast. The diagnosis of atopic bronchial asthma was established by medical doctors on the basis of data from the allergic anamnesis, the results of allegen skin prick test, epidemiology, and the experiments of nasal provokers and inhalers. The work was conducted under the rules of the Committee of Ethics in the Laboratory of Clinical Immunology and Allergy of RKB.
Detection of antibody - antiDNA by enzyme immunoassay
The determination of the rate of antibody anti-double stranded DNA was performed by enzyme-linked immunosorbent assay (ELISA) , previously optimized in the laboratory of the State University of Kazan. The lyophilized DNA of erythrocyte of chicken was used as antigen. The blood serum samples were incubated for 40 minutes at 56 degrees of Celsius to inactivate the proteins of the complement system and to dissociate the immune complex. For the detection of the antibodies associated with DNA in the wells of the ELISA plate, peroxidase-conjugated to antibody against human anti-IgG was used. The response of the coloring of ELISA reaction was detected by spectrophotometer “Multiskan” in units of optical density at a wavelength of 492 nm.
Determination of extracellular DNA concentration
The determination of the concentration of extracellular DNA was performed by the fluorimetric method with the aid of the colouring Hoechst 33342 (bisbenzimide) as fluorochrome. The level of fluorescence in solutions was measured in quartz cuvettes with 0.6 ml of volume using a fluorescence spectrophotometer “Hitachi MPF-4” (Japan) at an excitation wavelength of 358 nm and an emission wavelength of 458 nm. To determine the rate of fluorescence of DNA in solution, we took into account the fluorescence of Hoechst solution (0.24 μg) contained in a TNE buffer.
Determination of circulating immune complexes (CIC) by the method of precipitation with polyethylene glycol (PEG)
The rate of CIC in the serum was determined by the method based on the selective precipitation of antigen-antibody complexes in 4.17% PEG having a molecular weight of 6000, followed by a photometric determination of the density of the precipitate.
Separation of CIC by the precipitation method with PEG
to obtain CIC from the blood serum of patients with atopic bronchial asthma, 0.5 ml of serum was incubated with 0.5 ml of 7.5% PEG in 0.1 M borate buffer for 1 hour at 4°C. The precipitate was washed twice with 3.5% PEG in 0.1 M buffer, and centrifuged at 2500 rpm/min for 20 min at 4°C. And then the sediment suspended in 0.5 ml of phosphate buffered saline (PBS) was added.
Isolation of T-lymphocytes
Lymphocytes were isolated by the standard method of zonal centrifugation proposed by Patel et al.  with a mixture of Ficoll-verograffin (ρ = 1077 g cm-1) [20, 21]. This method consists of isolating 95% of T- lymphocytes and their viability was determined by the trypan blue exclusion method .
Culture of lymphocytes
The cells obtained (2 × 106) were diluted in 1 ml of the RPMI-1640 medium in plank made of plastic with flat bottom (Nung), then supplemented with 10% serum of foetal calf and 10 μl of L-glutamine (200 μg/ml) (Flow) . The cells were cultured with or without dexamethasone (final concentration of 10-4М) and then samples were incubated in СО2-incubator (5% СО2) for 1 - 6 days [24, 25].
To study the morphology of the cells, cells obtained after zonal centrifugation were precipitated successively in 2.5% glutaraldehyde and 1% OsO4 for 1 hour . The sample was then immersed in Epon 810 after being dehydrated with ethanol (30-96 degrees of Celsius), in acetone and propylene oxide. Then the cutting was realized with the aid of ultra-microtome LKB-3 followed by the observation with an electronic microscope (Hitachi 125, Japan)  after placing the material in the uranyl acetate and lead citrate for the contraction.
Determination of apoptosis
the quantification of apoptosis of lymphocytes was performed by the method of flow cytometry on FACSCalibur device (“Весton Dickinson”) with the use of some parameters, such as the determination of the fragmentation of DNA by the iodide propidium (IP) (“Sigma”) , the translocation of membrane phosphatidylserines to the surface of lymphocytes using merocyanine (МС540), the measuring of the variation in mitochondrial membrane potential of lymphocytes according to the fluorescence intensity CMX-Ros (“Molecular Probes”) . More than 10, 000 cells were counted on each variant of the experiment.
the analysis was performed using Excel program and Statistics 5.0. Comparison of ranges of variation was done with non-parametric criteria of Kryckaya Yollica and T- criteria of Manna Yitni. The authenticity of the frequency difference of the indices encountered was determined using the method of Fischer and t-test and partly with correction of Bonfferoni. The correctional analysis was performed by the method of Rank and Cpirmena-rs.
The content of antibodies against double-stranded DNA and the content of CIC in the blood of patients with ABA
Programmed cell death of lymphocytes of patients with ABA
In a physiopathological context, asthma is a chronic inflammatory disease of the respiratory airways  and the choice of the study of programmed cell death is particularly due to the fact that these lymphocytes play an irrecusable role in the pathogenesis of asthma [17, 32, 33]. Despite the plentiful data on asthma, the concept of PCD in the pathogenesis of asthma is and remains misunderstood and controversial [34, 35]. Increasing interest in this process of PCD  in recent years was fundamental to conduct this present study. During the development of asthma a multitude of Immunogenetic mechanism and cells of immune systems might be involved . The results of immunological studies suggest a number of changes in the functional state of lymphocytes in patients with asthma. In 1995 Szczeklik et al.  while studying the autoimmune status of patients suffering from Bronchial asthma, found in the blood some antinuclear antibodies, in any case, none of the patients got some antibodies with NDNA, however, the quantity of autoimmunity of the patients suffering from bronchial pulmonary system reveal the advantage of the synthesis of specific organ antibody, for example NDNA and/or DNDNA autoantibodies . Therefore, the level of IgG anti -NDNA increased significantly according to the degree of severity of asthma (Figure 2) and given that IgG have the ability to be locked up in the tissues, one could think of a lesion of target tissues in progressive course with the severity degree of the disease. It was revealed in patients with asthma the significant presence of CIC of average size and considered as the most pathogenic of CIC which was formed during a slight plethora of antigens. In relatively healthy donors, a process of enlargement of chronic CIC was observed and this in accordance with a proportional relationship of the level of antigen and antibody corresponding to their elimination. It should be noted that we recorded a direct relationship of dependence between the concentration of CIC and the level of antibodies against DNA and inverse dependence between the concentration of CIC and the concentration of extracellular DNA in the blood (Figure 6). This leads us to suggest the absence of a relation of equivalence between the antibody and the antigen during the progression of the severity degree of asthma. The existence of CIC in the blood is a normal and natural phenomenon of immune reactions. But their high level constitutes a means of diagnosing the pathology. Circulating immune complexes of large size are less soluble and can be easily removed by macrophages unlike CIC of medium and small size. They dissolve easily, making their removal difficult, which explains the CIC concentrations of medium and small size in asthmatics with serious severity. Therefore, the conception of the role played by the immune process in the pathogenesis of asthma is widely acknowledged, however, the importance of indicators of diagnosis and individual prognosis of the immune system remains poorly studied and in particular the accumulation in biological fluids IG antibodies - anti DNA, abzymes with DNAse activities, extracellular DNA, and CIC according to the degree of severity of the disease. The results obtained in this study allow us to suggest that these markers play a vital role in the pathogenesis of autoimmune process during asthma. And it is not excluded that these immunological characteristics stemmed from other natural physiological process. Thus, the observed difference underlined in the mitotic activity and the variation of the level of lymphocytes in culture of clinically healthy donors and asthmatic shows varying degrees of cell survival according to the severity of the disease. From the results of our work we could note that, based on a slowing of cell growth of lymphocytes from asthmatics with severe severity, the lymphocytes of asthmatics with mild severity are characteristic of lymphoproliferous activity in vitro. For the researches on asthma we do not often take into account the severity of asthma. Patients with asthma of mild and severe severity have different backgrounds and do not have the same degree of deficiency of the immune system. Failure to take into account the degree of severity could lead to false reasoning of statistical analysis. We found after our study that PCD of lymphocytes of patients manifested differently based on their degree of severity. Further to the adoption of the concept of PCD of type 1, the death of lymphocytes under the influence of certain doses of glucocorticoids was considered a classic model of apoptosis [40, 41]. Recently data were published on the sensitivity of subpopulations of lymphocytes of peripheral blood particularly cytotoxic and NK lymphocytes at a high dose of dexamethasone [42, 43]. The use of systemic glucocorticoids increases systematically the number of lymphocytes in the dipodiploide area. This confirms the hypothesis that the use of corticosteroids inhibit cytokine production (Ile 3, 4, 5) which keeps the high level of Bcl-2 anti apoptotic protein) and consequently leads to an acceleration of apoptosis lymphocytes [24, 44]. On the other hand, studies showed that the use of dexamethasone leads to a decrease in the number of migrating cells in the lungs after inhalation of specific allergens . The dexamethasone as inductor of apoptosis is expected to influence the number of proliferating cells especially their reduction [46, 47]. But according to our data, the lymphocytes of asthmatic patients with mild severity showed resistance to glucocorticoids followed by active proliferation of its cells. There was also a decrease in the number of cells in the late phase of apoptosis. This may be due to a malfunction of the expression of DNase responsible for DNA degradation. It is conceivable in view of these results that there are indeed particularities in the course of apoptosis, in asthmatics and this according to the degree of severity of the disease. However, even if the conditions of the body seem to be met to artificially induce apoptosis, the results obtained could not totally be those of internal conditions. Several parameters can influence the results. Researches on apoptosis still continue nowadays, it may be other unknown physiological parameters which determine the course of this process, of which the absence would influence the results. Asthma can also be linked to a genetic predisposition, and even from a race to another, differences can be observed. Thus, results on the morphology of lymphocytes of asthmatics were obtained. And most of lymphocytes had specific morphological characteristics. Sometimes, cells with characteristics of autophagosomes autophagy were found [29, 48]. The presence of autophagy could explain the decrease of apoptotic cells in asthmatics with mild severity. And the PCD is universally prevalent in the world of multicellular organisms, and affects all types of tissues. It operates according to the biochemical and morphological parameters strictly defined and do not depend on the causes leading to the initiation of this process. In addition, the study of PCD is very productive to understand a certain number of important processes including immune homeostasis. Finally, according to new data, it has become essential and indispensable to review a certain number of conceptual bases of physiopathology and immunopathology.
Autoimmunity and Programmed Cell Death are a highly conserved and integrated response in normal physiological processes playing a vital role in the pathogenesis of various diseases, especially in the development of asthma.
The authors thank Federation of Russia and University of Parakou.
- Nagata S: Apoptosis by death factor. Cell. 1997, 88: 355-365. 10.1016/S0092-8674(00)81874-7.View ArticlePubMedGoogle Scholar
- Jacobson MD, Weil M, Raff MC: Programmed cell death in animal development. Cell. 1997, 88: 347-354. 10.1016/S0092-8674(00)81873-5.View ArticlePubMedGoogle Scholar
- Barber GN: Host defense, viruses and apoptosis. Cell Death Differ. 2001, 8: 113-126. 10.1038/sj.cdd.4400823.View ArticlePubMedGoogle Scholar
- Okada H, Mak TW: Pathways of apoptotic and non-apoptotic death in tumor cells. Nat Rev Cancer. 2004, 4: 592-603. 10.1038/nrc1412.View ArticlePubMedGoogle Scholar
- Vodounon ACJ, Baba-Moussa L, Skibo YV, Sezan A, Abramova ZI: The Implication of Morphological Characteristics in the Etiology of Allergic asthma Disease and in Determining the Degree of Severity of Atopic and Bronchial Asthma. Asian J Cell Biol. 2011, 6: 65-80. 10.3923/ajcb.2011.65.80.View ArticleGoogle Scholar
- Moskaleva E, Severin SE: Possible mechanisms of adaptation of cells damage, inducing programmed death, the relationship with the pathology. Pathol Physiol Exp Ther. 2006, 2: 2-16.Google Scholar
- Мansky ВН: Ways to cell death and their biological significance. Cytology. 2007, 49 (11): 909-914.Google Scholar
- Edinger AZ, Thompson C: Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004, 16: 663-669. 10.1016/j.ceb.2004.09.011.View ArticlePubMedGoogle Scholar
- Lockshin RA, Zakeri Z: Apoptosis, autophagy, and more. JBCB. 2004, 36: 2405-2419.Google Scholar
- Kando Y, Kanzawa T, Sawaya R, Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Canc. 2005, 5: 726-734. 10.1038/nrc1692.View ArticleGoogle Scholar
- Levine B, Klionsky DJ: Development by self-digestion: molecular machanisms and biological functions of autophagy. Dev Cell. 2004, 6: 463-477. 10.1016/S1534-5807(04)00099-1.View ArticlePubMedGoogle Scholar
- Levine B, Yuan J: Autophagy in cell death: an innocent convict?. J Clin Investig. 2005, 115: 2679-2688. 10.1172/JCI26390.PubMed CentralView ArticlePubMedGoogle Scholar
- Nishino I: Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep. 2003, 3: 64-69. 10.1007/s11910-003-0040-y.View ArticlePubMedGoogle Scholar
- Meijer AJ, Codogno JP: Regulation and role of autophagy in mammalian cells. IJBCB. 2004, 36: 2445-2462.Google Scholar
- Urbonien D, Skalauskas R, Sitkauskiene B: Autoimmunity in pathogenesis of chronic obstructive pulmonary disease. Medicina (Kaunas). 2005, 41 (3): 190-195.Google Scholar
- Yarilin AA: Fundamentals of Immunology. 1999, Moscow: Meditsina PublishersGoogle Scholar
- Barnes PJ, Adcock IM: How do corticosteroides work in asthma?. Ann Intern Med. 2003, 139: 359-370. 10.7326/0003-4819-139-5_Part_1-200309020-00012.View ArticlePubMedGoogle Scholar
- Goldsby RA, Kindt TJ, Osborn BA: Enzyme-linked Immunosorbent Assay. Immunology. 2003, 5: 148-150.Google Scholar
- Patel D, Rubbi CP, Rickwood D: Separation of T and B lymphocytes from human peripheral blood mononuclear cells using density perturbation methods. Clin Chim Acta. 1995, 240: 187-193. 10.1016/0009-8981(95)06141-9.View ArticlePubMedGoogle Scholar
- Heyfits LB, Abalkin VA: Separation of human blood cells in a density gradient Ficoll-verografin. Lab Work. 1973, 10: 579-581.Google Scholar
- Antoneeva II: Differentiation and activation-associated markers of peripheral blood lymphocytes in the patients with ovarian in the course of tumor progression. Med Immunol. 2007, 6: 649-652.Google Scholar
- Khorshid FA, Moshref SS: In vitro anticancer agent, I-tissue culture study of human lung cancer cells A549 II-tissue culture study of mice leukemia cells L1210. Int J Canc Res. 2006, 2: 330-344.View ArticleGoogle Scholar
- Soroka NF, Svirnovski AI, Rekun AL: Effect of immunosuppressive drugs on apoptosis of lymphocytes of patients with systemic lupus erythematosus in vitro. Sci Pratic Rheumatol. 2007, 1: 15-21.Google Scholar
- Boychuk SV, Mustafin IG, Fassahov RS: Mechanisms of dexamethasone-induced apoptosis of lymphocytes in atopic asthma. Pulmonology. 2003, 2: 10-16.Google Scholar
- Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O: Induction of T-lymphocytes apoptosis by sulphasalazine in patients with Crohn's disease. Gut. 2004, 53: 1632-1638. 10.1136/gut.2003.037911.PubMed CentralView ArticlePubMedGoogle Scholar
- Abdelmeguid NE, Mostafa MH, Abdel-Moneim AM, Badawi AF, Abou Zeinab NS: Tamoxifen and melatonin differentially influence apoptosis of normal mammary gland cells: Ultrastructural evidence and p53 expression. Int J Canc Res. 2008, 4: 81-91. 10.3923/ijcr.2008.81.91.View ArticleGoogle Scholar
- Sanders EJ, Wride MA: Ultrastructural identification of apoptotic nuclei using the TUNEL technique. Histochem J. 1996, 28: 275-281. 10.1007/BF02409015.View ArticlePubMedGoogle Scholar
- Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth. 1991, 139: 271-279. 10.1016/0022-1759(91)90198-O.View ArticleGoogle Scholar
- Melis M, Siena L: Fluticasone induces apoptosis in peripheral T-lymphocytes: a comparison between asthmatic and normal subjects. Eur Respir J. 2002, 19: 257-266. 10.1183/09031936.02.00239202.View ArticlePubMedGoogle Scholar
- Reichlin NT, Reichlin AN: Apoptosis regulation and manifestation in physiological conditions and tumors. Probl Oncol. 2002, 48: 159-171.Google Scholar
- Lee J-H, Yu H-H, Wang L-C, Yang Y-H, Lin Y-T, Chiang B-L: The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol. 2007, 148 (1): 53-63. 10.1111/j.1365-2249.2007.03329.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Vignola AM: Airway Inflammation in Mild Intermittent and in Persistent Asthma. Am J Respir Crit Care Med. 1998, 157 (2): 403-409. 10.1164/ajrccm.157.2.96-08040.View ArticlePubMedGoogle Scholar
- Mammoth TV, Kaidashev IP: New aspects of the apoptosis of mononuclear cells in the pathogenesis of atopic asthma. Allergology. 2005, 4: 15-23.Google Scholar
- Deponte M: Programmed cell death in protists. Biochem Biophys Acta. 2008, 1783: 1396-1405. 10.1016/j.bbamcr.2008.01.018.View ArticlePubMedGoogle Scholar
- Jiménez C, Capasso JM, Edelstein CL: Different ways to die: cell death modes of the unicellular chlorophyte Dunaliella viridis exposed to various environmental stresses are mediated by the caspase-like activity DEVDase. J Exp Bot. 2009, 3: 815-828.View ArticleGoogle Scholar
- Bidle KD, Falkowski PG: Cell death in planktonic, photosynthetic microorganisms. Nat Rev Microbiol. 2004, 2: 643-655. 10.1038/nrmicro956.View ArticlePubMedGoogle Scholar
- Wiik AS, Gordon TP, Kavanaugh AF, Lahita RG, Reeves W, van Venrooij WJ, Wilson MR, Fritzler M: Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum. 2004, 51: 291-298. 10.1002/art.20229.View ArticlePubMedGoogle Scholar
- Szczeklik А, Nizankowska E, Serafin A: Autoimmune phenomena in bronchial asthma with special reference tо aspirin intolerance. Am J Respir Crit Care Med. 1995, 6: 1753-1756.View ArticleGoogle Scholar
- Markin OA, Yastrebova HE, Vaneva HP: Autoantibodies in children with chronic inflammatory lung diseases. Zh Mikrobiol Epidemiol Immunobiol. 2001, 6: 52-55.Google Scholar
- Kaznatheev K, Kaznatheev KS, LF Kaznacheeva LF, Molokov AV: Apoptosis cell in children with atopic dermatitis during the application of the cream “Skin-Cap”. Allergy. 2006, 3: 7-11.Google Scholar
- Majino G, Majino G, Joris I: Apoptosis, oncosis and necrosis. An overview of cell death. J Pathol. 1995, 146 (1): 3-15.Google Scholar
- Leung D: Pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 1999, 104: 99-108.View ArticleGoogle Scholar
- Kungurov NV, Gerasimov NM, Kohan MM: Atopic dermatitis. Types of course, the principles of therapy. 2000, Ekaterinburg: , 272-Google Scholar
- Mineev VN, Nesterovich II, Orange ES, Tafer AL: Apoptosis and the activity of ribosomal cistrons in peripheral blood cells in bronchial asthma. Allergology. 2003, 3: 15-19.Google Scholar
- O’Sullivan S, Cormican L, Burke CM: Fluticasone induces T cell apoptosis in the bronchial wall of mild to moderate asthmatics. Asthma. 2004, 59 (8): 657-661.Google Scholar
- Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM: Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci. 2005, 42: 71-104. 10.1080/10408360590888983.View ArticlePubMedGoogle Scholar
- Frankfurt O, Rosen ST: Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol. 2004, 16: 553-563. 10.1097/01.cco.0000142072.22226.09.View ArticlePubMedGoogle Scholar
- Degenhardt K, Mathew R, Beaudoin B, Chen G: Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006, 10: 51-64. 10.1016/j.ccr.2006.06.001.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.